CHIRON REAL ESTATE

In Q1 2026 Chiron Real Estate executed a strategic realignment focusing on senior living properties and plans to keep at least 25% of its portfolio in operator-run senior housing. The company cut its monthly distribution to $0.16 per share, freeing about $15 million annually for reinvestment. Maewyn Capital is investing $100 million to accelerate growth; the 2026 guidance was withdrawn. FFO is $0.97 (Core FFO $1.11) and net leverage has fallen to 6.6x adjusted EBITDA. » More on de.investing.com

Chiron Real Estate has agreed to an investment of up to $100 million in the form of perpetual series C convertible preferred shares with deferred drawdown, led by Maewyn Capital Partners. The preferred shares pay an annual dividend of 6.00% and are convertible into common shares at any time at $43.00; this corresponds to roughly 21% upside versus the current price of $35.51. Chiron may repurchase the shares after four years and will issue warrants upon repurchase; Maewyn will also receive a board seat following the annual general meeting on May 20, 2026. » More on de.investing.com

Chiron Real Estate (formerly GMRE) reported Q4-2025 Core FFO of $1.16 per share and NAREIT FFO of $0.97. Same-store cash NOI rose 5.4%, and net leverage stands at 6.2x adjusted EBITDAre. The company is repositioning as a diversified healthcare real estate platform focused on senior housing and active adult communities, is introducing a monthly dividend with an annualized rate of $3.00, and gives 2026 Core FFO guidance of $4.30–4.45, which includes a $0.36 headwind from balance-sheet actions. » More on de.investing.com